Jane Street
PHXM

Jane Street’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Jane Street’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,867
Closed -$93K – 11240
2022
Q1 		$93K Buy
4,867
+303
+7% +$5.73K ﹤0.01% 9489
2021
Q4 		$110K Buy
+4,564
New +$154K ﹤0.01% 9193
2018
Q1 		– Sell
-2,734
Closed -$607K – 5561
2017
Q4 		$607K Buy
+2,734
New +$645K ﹤0.01% 2946

Other funds holding PHXM

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Personalized Indexing Management
Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jane Street's PHXM Position: Q2 2022 in Review

Jane Street sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q2 2022, closing a stake of 4,867 shares — an estimated $93K sold.

Jane Street first reported a position in PHXM in Q4 2017 and held it in 3 quarters. The position peaked at $607K in Q4 2017. 6 funds tracked by Wall St. Rank hold PHXM as of Q2 2022.

  • Jane Street reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Jane Street sold 4,867 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q2 2022, an estimated $93K.
  • Jane Street first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 3 quarters.
  • Jane Street's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $607K in Q4 2017.
  • 6 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.